Labeling of A2A adenosine receptors in human platelets by use of the new nonxanthine antagonist radioligand [3H]SCH 58261

Journal of Pharmacology and Experimental Therapeutics

Volumn 278, Issue 3, 1996, Pages 1209-1214

  Dionisotti, Silvio ^a   Ferrara, Silvia ^a   Molta, Cristina ^a   Zocchi, Cristina ^a   Ongini, Ennio ^a  

^a Schering Plough Research Institute   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 AMINO 2 (2 FURYL) 7 (2 PHENYLETHYL)PYRAZOLO[4,3 E][1,2,4]TRIAZOLO[1,5 C]PYRIMIDINE; 5 AMINO 7 (2 PHENYLETHYL) 2 (2 FURYL) PYRAZOLO[4,3] 1,2,4 TRIAZOLO[1,5]PYRIMIDINE; ADENOSINE A2 RECEPTOR; RADIOLIGAND; UNCLASSIFIED DRUG; ADENOSINE RECEPTOR; PYRIMIDINE DERIVATIVE; TRIAZOLE DERIVATIVE;

ARTICLE; COMPETITIVE INHIBITION; DRUG RECEPTOR BINDING; ENZYME ACTIVATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LABELING INDEX; LIGAND BINDING; PRIORITY JOURNAL; RECEPTOR AFFINITY; SOLUBILIZATION; THROMBOCYTE AGGLUTINATION; BINDING COMPETITION; CELL FREE SYSTEM; CELL MEMBRANE; CHEMISTRY; DRUG ANTAGONISM; DRUG POTENTIATION; KINETICS; METABOLISM; PROTEIN BINDING; RADIOASSAY; THROMBOCYTE;

BINDING, COMPETITIVE; BLOOD PLATELETS; CELL MEMBRANE; CELL-FREE SYSTEM; HUMANS; KINETICS; PROTEIN BINDING; PYRIMIDINES; RADIOLIGAND ASSAY; RECEPTORS, PURINERGIC P1; TRIAZOLES;

EID: 0030302479     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. 2A adenosine receptor antagonists. Bioorg. Med. Chem. Lett. 4: 2539-2544, 1994.
2. 3H]NECA in rat striatal membranes. Mol. Pharmacol. 29: 331-346, 1986.
3. 2 receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 335: 64-69, 1987.
4. COATES, J., GURDEN, M. F., HARRIS, C., KENNEDY, I., SHEEHAN, M. J. AND STRONG, P.: Adenosine receptor classification: quo vadimus? Nucleosides & Nucleotides 13: 1953-1976, 1994.
5. COLLIS, M. G. AND HOURANI, S. M. O.: Adenosine receptor subtypes. Trends Pharmacol. Sci. 14: 360-366, 1993.
6. 2 adenosine receptors. J. Med. Chem. 35: 2365-2368, 1992.
7. CRISTALLI, G., VITTORI, S., THOMSON, R. D., PADGETT, W. L., SHI, D., DALY, J. W. AND OLSSON, R. A.: Inhibition of platelet aggregation by adenosine receptor agonists. Naunyn-Schmiedeberg's Arch. Pharmacol. 349: 644-650, 1994.
8. DIONISOTTI, S., ZOCCHI, C., VARANI, K., BOREA, P. A. AND ONGINI E.: Effects of adenosine derivatives on human and rabbit platelet aggregation. Correlation of adenosine receptor affinities and antiaggregatory activity. Naunyn-Schmiedeberg's Arch. Pharmacol. 346: 673-676, 1992.
9. FEIN, T., SCHULZE, E., BÄR, J. AND SCHWABE, U.: Purification and characterization of an adenotin-like adenosine binding protein from human platelets. Naunyn-Schmiedeberg's Arch. Pharmacol. 349: 374-380, 1994.
10. FREDHOLM, B. B., ABBRACCHIO M. P., BURNSTOCK, G., DALY, J. W., HARDEN, T. K., JACOBSON, K. A., LEFF, P. AND WILLIAMS, M.: Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46: 143-156, 1994.
11. 2a adenosine receptors from rat striatum and rat pheochromocytoma PC 12 cells: characterization with radioligand binding and by activation of adenylate cyclase. Mol. Pharmacol. 41: 352-359, 1992.
12. HUTCHISON, K. A., NEVINS, B., PERINI, F. AND FOX, I. H.: Soluble and membrane-associated human low-affinity adenosine binding protein (adenotin): Properties and homology with mammalian and avian stress proteins. Biochemistry 29: 5138-5144, 1990.
13. 3H]adenosine binding in relation to adenylate cyclase activity. Naunyn-Schmiedeberg's Arch. Pharmacol. 325: 226-233, 1984.
14. 2 receptors in rat brain. J. Pharmacol. Exp. Ther. 251: 888-893, 1989.
15. 2 receptor. Biochem. Pharmacol. 21: 3827-3833, 1989.
16. 3H]NECA binding sites by gel filtration. Naunyn-Schmiede berg's Arch. Pharmacol. 337: 64-68, 1988.
17. LOWRY, O. H., ROSEBROUGH, N. J., FAHR, A. I. AND RANDALL, R. J.: Protein measurement with Folin phenol reagent. J. Biol. Chem. 193: 265-275, 1951.
18. MUNSON, P. J. AND RODBARD, P.: LIGAND: a versatile computerized approach for characterization of ligand-binding systems. Anal. Biochem. 107: 220-239, 1980.
19. 2 receptor antagonist, to rat brain membranes. Mol. Pharmacol. 46: 817-822, 1994.
20. PAUL, S., FEOKTISTOV, I., HOLLISTER, A. S., ROBERTSON, D. AND BIAGGIONI, I.: Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: Evidence that both effects are coupled to adenylate cyclase. Mol. Pharmacol. 37: 870-875, 1990.
21. 2 antagonists. J. Med. Chem. 35: 2342-2345, 1992.
22. SCHÜTZ, W., TUISL, E. AND KRAUPP, O.: Adenosine receptor antagonists: binding and adenylate cyclase stimulation in rat liver plasma membranes. Naunyn-Schmiedeberg's Arch. Pharmacol. 319: 34-39, 1982.
23. UKENA, D., BÖHME, E. AND SCHWABE, U.: Effects of several 5′-carboxamide derivatives of adenosine on adenosine receptors of human platelets and rat fat cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 327: 36-42, 1984.
24. 3H] amine congener of 1,3-dipropyl-8-phenylxanthine. A new radioligand for A2 adenosine receptors of human platelets. FEBS Lett. 199: 269-274, 1986.
25. 2A receptors: Structure function relationships. Med. Res. Rev. 12: 423-471, 1992.
26. 3H]-CGS 21680 in human platelets. Biochem. Pharmacol. 48: 1658-1661, 1994.
27. 3H]-CGS 21680 binding. Br. J. Pharmacol. 117: 1693-1701,1996.
28. 3H]5′-N-ethylcarboxamidoadenosine binds to both Ra and Ri adenosine receptors in rat striatum. Naunyn-Schmiedeberg's Arch. Pharmacol. 325: 218-225, 1984.
29. 2A adenosine receptor antagonist. J. Pharmacol. Exp. Ther. 276: 398-404, 1996a.
30. 2A adenosine receptor antagonist, to rat striatal membranes. Br. J. Pharmacol. 117: 1381-1386, 1996b.
31. 2-like binding protein. Mol. Pharmacol. 37: 554-559, 1990.